Tumor ablation is a minimally invasive procedure to remove the tumor cells or tissue from the body. Tumor ablation devices are consists of a catheter, which is introduced into the tumor under imaging guidance. Advancements in cryosurgical technology and intraoperative monitoring devices have gained the adoption of tumor ablation devices by the healthcare professionals. As this technology have led to the implementation of high accuracy and precision in treating chronic diseases such as a liver tumor. The use of Microwave Ablation magnetic image-guiding systems has provided an effective adjunct in laparoscopic ablation and helps in providing better support to surgeons and increases clinical patient outcome.

Download PDF Brochure of Research Report:
https://www.coherentmarketinsights.com/insight/request-pdf/1270

Market Dynamics
Rising prevalence of tumor cases is the major factor that contributes in the growth of the tumor ablation devices market. According the Central Brain Tumor Registry of the US (CBTRUS), 2015, there are over 138,000 people in the US living with primary brain and central nervous system malignant tumors. Various key players are involved in sustainable development of minimally invasive ablation devices for various types such as catheter ablation, cryoablators, etc. Moreover, key players are also indulged in offering various lucrative features to the potential buyers of the ablation devices such as hospitals and clinics that would in turn help them to grow their sales and establish a global market presence. For instance, Medtronic launched OsteoCool RF Ablation System to treat spine metastases, in January 2016. The system destroys cancer cells by using high frequency energy, and also provides procedural flexibility and tailored treatment for spine metastases. However, cost of the tumor treatment is relatively expensive which may restraint the growth of the market.

Request Customization:
https://www.coherentmarketinsights.com/insight/request-customization/1270

Emerging economies to fuel the market growth
On the basis of regional segmentation, the global tumor ablation devices market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is expected to account for the largest share followed by Europe and Asia Pacific. Tumor ablation devices market in North America is driven by factors, such as trend of replacing older technologies and introducing the new technologies, and increase in private and public funding to develop and commercialize the novel tumor ablation products. For instance, in 2016, EDAP TMS has made high-intensity focused ultrasound (HIFU) systems, robotic device that allows for the safe ablation of prostate tissue, available in the prestigious institutions such as USC in Los Angeles, University of Miami, Duke University, the Cleveland Clinic, thus building awareness, allowing global adoption of the technology with rapid U.S. market penetration.

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]